SP is a mitogen in ALL and AML, while an NK-1R antagonist, aprepitant, was shown to inhibit ALL and AML cells and induce apoptosis in ALL and AML cells [11,12]. Here, TACR1 is linked to acute lymphoblastic leukemia.